Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Immunocore Holdings PLC Sponsored ADR (IMCR) had Non-Operating Income/Expense of $7.47M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$103.69M |
|
$-0.18M |
|
$0.51M |
|
$103.18M |
|
$110.86M |
|
$-7.17M |
|
|
Non-Operating Income/Expense |
$7.47M |
$0.30M |
|
$0.30M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
$-7.17M |
|
$-6.37M |
|
50.40M |
|
50.40M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$1.02B |
|
$9.43M |
|
$79.65M |
|
$1.10B |
|
$170.35M |
|
$392.59M |
|
$535.58M |
|
$705.94M |
|
$396.56M |
|
$396.56M |
|
$396.56M |
|
50.47M |
|
| Cash Flow Statement Financials | |
$21.94M |
|
$-15.46M |
|
$8.09M |
|
$455.73M |
|
$498.41M |
|
$42.68M |
|
$29.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.00 |
|
-- |
|
-- |
|
0.50 |
|
0.99 |
|
99.51% |
|
-6.92% |
|
-6.92% |
|
-- |
|
0.29% |
|
-0.17% |
|
$20.48M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.09 |
|
1.37 |
|
65.86 |
|
-0.04% |
|
-0.04% |
|
-0.02% |
|
-0.02% |
|
$7.86 |
|
$0.41 |
|
$0.44 |
|